Kocaturk, E.Baskan, E. B.Engin, B.Ozdemir, M.KÜÇÜK, ÖZLEM SUCan, P.Ornek, S.Hasal, E.Atakan, N.2020-10-222020-10-222019-08-01http://hdl.handle.net/20.500.12645/24428Kocaturk E., Baskan E. B. , Engin B., Ozdemir M., KÜÇÜK Ö. S. , Can P., Ornek S., Hasal E., Atakan N., -Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?-, Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.484-485Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?Conference PaperWOS:000480254003224